Comparison of urine protein profiles in cats without urinary tract disease and cats with idiopathic cystitis, bacterial urinary tract infection, or urolithiasis

Stephanie I. K. Lemberger Clinic of Small Animal Medicine, Faculty of Veterinary Medicine, Ludwig Maximilian University, 80539 Munich, Germany.

Search for other papers by Stephanie I. K. Lemberger in
Current site
Google Scholar
PubMed
Close
 DVM, Dr. med. vet.
,
Cornelia A. Deeg Institute of Animal Physiology, Department of Veterinary Sciences, Faculty of Veterinary Medicine, Ludwig Maximilian University, 80539 Munich, Germany.

Search for other papers by Cornelia A. Deeg in
Current site
Google Scholar
PubMed
Close
 DVM, Dr. med. vet., Dr. habil.
,
Stefanie M. Hauck Department of Protein Science, Helmholtz Center Munich—German Research Center for Environmental Health GmbH, 85764 Neuherberg, Germany.

Search for other papers by Stefanie M. Hauck in
Current site
Google Scholar
PubMed
Close
 Dr. rer. nat.
,
Barbara Amann Institute of Animal Physiology, Department of Veterinary Sciences, Faculty of Veterinary Medicine, Ludwig Maximilian University, 80539 Munich, Germany.

Search for other papers by Barbara Amann in
Current site
Google Scholar
PubMed
Close
,
Sieglinde Hirmer Institute of Animal Physiology, Department of Veterinary Sciences, Faculty of Veterinary Medicine, Ludwig Maximilian University, 80539 Munich, Germany.

Search for other papers by Sieglinde Hirmer in
Current site
Google Scholar
PubMed
Close
,
Katrin Hartmann Clinic of Small Animal Medicine, Faculty of Veterinary Medicine, Ludwig Maximilian University, 80539 Munich, Germany.

Search for other papers by Katrin Hartmann in
Current site
Google Scholar
PubMed
Close
 DVM, Dr. med. vet., Dr. habil.
, and
Roswitha Dorsch Clinic of Small Animal Medicine, Faculty of Veterinary Medicine, Ludwig Maximilian University, 80539 Munich, Germany.

Search for other papers by Roswitha Dorsch in
Current site
Google Scholar
PubMed
Close
 DVM, Dr. med. vet.

Abstract

Objective—To characterize and compare the urine protein content in cats without urinary tract disease and cats with idiopathic cystitis (IdC), bacterial urinary tract infection (UTI), or urolithiasis.

Animals—Control cats (n = 18) and cats with IdC (18), UTI (12), and urolithiasis (12) from which urine samples were obtained and 2 cats with obstructive IdC and 4 additional control cats from which postmortem urinary bladder biopsy specimens were obtained.

Procedures—Protein contents in urine samples obtained via cystocentesis or catheterization were measured via the Bradford method. Urine proteins were separated by means of 1-dimensional gel electrophoresis. Evaluation of fibronectin content was performed via western blotting and immunohistochemical analysis. Urinary bladder biopsy specimens were examined histologically and analyzed immunohistochemically for fibronectin.

Results—Urine fibronectin content was significantly greater in cats with IdC, compared with control cat findings. Urine fibronectin contents did not differ significantly among controls and cats with UTI or urolithiasis. Histologic examination of bladder biopsy specimens obtained from 2 cats with obstructive IdC revealed destruction of the urothelial lining of the urinary bladder and severe fibrosis; immunohistochemical analysis revealed few fluorescence signals for fibronectin, unlike findings in control bladder biopsy specimens.

Conclusions and Clinical Relevance—Results indicated that urine fibronectin content in cats with IdC was greater than that in controls, cats with UTI, or cats with urolithiasis. In cats with IdC, increased permeability of damaged urothelium may result in detachment and leakage of fibronectin into urine. Urine fibronectin might serve as a biomarker for diagnosis of IdC in cats.

Abstract

Objective—To characterize and compare the urine protein content in cats without urinary tract disease and cats with idiopathic cystitis (IdC), bacterial urinary tract infection (UTI), or urolithiasis.

Animals—Control cats (n = 18) and cats with IdC (18), UTI (12), and urolithiasis (12) from which urine samples were obtained and 2 cats with obstructive IdC and 4 additional control cats from which postmortem urinary bladder biopsy specimens were obtained.

Procedures—Protein contents in urine samples obtained via cystocentesis or catheterization were measured via the Bradford method. Urine proteins were separated by means of 1-dimensional gel electrophoresis. Evaluation of fibronectin content was performed via western blotting and immunohistochemical analysis. Urinary bladder biopsy specimens were examined histologically and analyzed immunohistochemically for fibronectin.

Results—Urine fibronectin content was significantly greater in cats with IdC, compared with control cat findings. Urine fibronectin contents did not differ significantly among controls and cats with UTI or urolithiasis. Histologic examination of bladder biopsy specimens obtained from 2 cats with obstructive IdC revealed destruction of the urothelial lining of the urinary bladder and severe fibrosis; immunohistochemical analysis revealed few fluorescence signals for fibronectin, unlike findings in control bladder biopsy specimens.

Conclusions and Clinical Relevance—Results indicated that urine fibronectin content in cats with IdC was greater than that in controls, cats with UTI, or cats with urolithiasis. In cats with IdC, increased permeability of damaged urothelium may result in detachment and leakage of fibronectin into urine. Urine fibronectin might serve as a biomarker for diagnosis of IdC in cats.

Contributor Notes

Supported by the Deutsche Forschungsgemeinschaft (DFG) SFB 571 A5 Deeg.

Presented in abstract form at the European College of Veterinary Internal Medicine Congress, Porto, Portugal, September 2009.

The authors thank Dr. Carola Sauter-Louis for statistical assistance and Dr. Walter Hermanns for obtaining the full-thickness urinary bladder biopsy specimens.

Address correspondence to Dr. Dorsch (r.dorsch@medizinischekleintierklinik.de).
  • 1.

    Lund EM, Armstrong PJ, Kirk CA, et al. Health status and population characteristics of dogs and cats examined at private veterinary practices in the United States. J Am Vet Med Assoc 1999; 214: 13361341.

    • Search Google Scholar
    • Export Citation
  • 2.

    Patronek GJ, Glickman LT, Beck AM, et al. Risk factors for relinquishment of cats to an animal shelter. J Am Vet Med Assoc 1996; 209: 582588.

    • Search Google Scholar
    • Export Citation
  • 3.

    Cameron ME, Casey RA, Bradshaw JW, et al. A study of environmental and behavioural factors that may be associated with feline idiopathic cystitis. J Small Anim Pract 2004; 45: 144147.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 4.

    Lekcharoensuk C, Osborne CA, Lulich JP. Epidemiologic study of risk factors for lower urinary tract diseases in cats. J Am Vet Med Assoc 2001; 218: 14291435.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 5.

    Gunn-Moore DA. Feline lower urinary tract disease. J Feline Med Surg 2003; 5: 133138.

  • 6.

    Westropp JL, Kass PH, Buffington CAT. In vivo evaluation of α2-adrenoceptors in cats with idiopathic cystitis. Am J Vet Res 2007; 68: 203207.

  • 7.

    Lavelle JP, Meyers SA, Ruiz WG, et al. Urothelial pathophysiological changes in feline interstitial cystitis: a human model. Am J Physiol Renal Physiol 2000; 278:F540F553.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 8.

    Keay S, Zhang CO, Kagen DI, et al. Concentrations of specific epithelial growth factors in the urine of interstitial cystitis patients and controls. J Urol 1997; 158: 19831988.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 9.

    Oravisto KJ. Epidemiology of interstitial cystitis. Ann Chir Gynaecol Fenn 1975; 64: 7577.

  • 10.

    Kruger JM, Osborne CA, Lulich JP. Changing paradigms of feline idiopathic cystitis. Vet Clin North Am Small Anim Pract 2009; 39: 1540.

  • 11.

    Keay S, Seillier-Moiseiwitsch F, Zhang CO, et al. Changes in human bladder epithelial cell gene expression associated with interstitial cystitis or antiproliferative factor treatment. Physiol Genomics 2003; 14: 107115.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 12.

    Hanno P, Dmochowski R. Status of international consensus on interstitial cystitis/bladder pain syndrome/painful bladder syndrome: 2008 snapshot. Neurourol Urodyn 2009; 28: 274286.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 13.

    Neal DE. Interstitial cystitis: evaluation and related conditions. J Urol 2009; 181: 24142415.

  • 14.

    Buffington CA, Pacak K. Increased plasma norepinephrine concentration in cats with interstitial cystitis. J Urol 2001; 165: 20512054.

  • 15.

    Reche Junior A, Buffington CA. Increased tyrosine hydroxylase immunoreactivity in the locus coeruleus of cats with interstitial cystitis. J Urol 1998; 159: 10451048.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 16.

    Buffington CA. Developmental influences on medically unexplained symptoms. Psychother Psychosom 2009; 78: 139144.

  • 17.

    Keay S, Zhang CO, Trifillis AL, et al. Decreased 3H-thymidine incorporation by human bladder epithelial cells following exposure to urine from interstitial cystitis patients. J Urol 1996; 156: 20732078.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 18.

    Keay S, Zhang CO, Hise MK, et al. A diagnostic in vitro urine assay for interstitial cystitis. Urology 1998; 52: 974978.

  • 19.

    Keay S, Kleinberg M, Zhang CO, et al. Bladder epithelial cells from patients with interstitial cystitis produce an inhibitor of heparin-binding epidermal growth factor-like growth factor production. J Urol 2000; 164: 21122118.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 20.

    Hanno P, Keay S, Moldwin R, et al. International consultation on IC—Rome, September 2004/forging an international consensus: progress in painful bladder syndrome/interstitial cystitis. Report and abstracts. Int Urogynecol J Pelvic Floor Dysfunct 2005; 16 (suppl 1): S2S34.

    • Search Google Scholar
    • Export Citation
  • 21.

    Hauck SM, Schoeffmann S, Deeg CA, et al. Proteomic analysis of the porcine interphotoreceptor matrix. Proteomics 2005; 5: 36233636.

  • 22.

    Hauck SM, Ekstrom PA, Ahuja-Jensen P, et al. Differential modification of phosducin protein in degenerating rd1 retina is associated with constitutively active Ca2+/calmodulin kinase II in rod outer segments. Mol Cell Proteomics 2006; 5: 324336.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 23.

    Lemberger SI, Dorsch R, Hauck SM, et al. Decrease of Trefoil factor 2 in cats with feline idiopathic cystitis. BJU Int 2011; 107: 670677.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 24.

    Zipplies JK, Hauck SM, Schoeffmann S, et al. Serum PEDF levels are decreased in a spontaneous animal model for human autoimmune uveitis. J Proteome Res 2009; 8: 992998.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 25.

    Peters T Jr. Serum albumin: recent progress in the understanding of its structure and biosynthesis. Clin Chem 1977; 23: 512.

  • 26.

    Dobryszycka W. Biological functions of haptoglobin—new pieces to an old puzzle. Eur J Clin Chem Clin Biochem 1997; 35: 647654.

  • 27.

    Oida K, Takai H, Maeda H, et al. Apolipoprotein(a) is present in urine and its excretion is decreased in patients with renal failure. Clin Chem 1992; 38: 22442248.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 28.

    Lukin JA, Ho C. The structure-function relationship of hemoglobin in solution at atomic resolution. Chem Rev 2004; 104: 12191230.

  • 29.

    Gerber B, Boretti FS, Kley S, et al. Evaluation of clinical signs and causes of lower urinary tract disease in European cats. J Small Anim Pract 2005; 46: 571577.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 30.

    Hegele A, Heidenreich A, Varga Z, et al. Cellular fibronectin in patients with transitional cell carcinoma of the bladder. Urol Res 2003; 30: 363366.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 31.

    Danisman A, Bulut K, Kukul E, et al. Urinary fibronectin levels in patients treated with intravesical bacillus Calmette-Guerin for superficial bladder cancer. Urol Int 2000; 64: 198201.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 32.

    Pankov R, Yamada KM. Fibronectin at a glance. J Cell Sci 2002; 115: 38613863.

  • 33.

    Mosher DF. Physiology of fibronectin. Annu Rev Med 1984; 35: 561575.

  • 34.

    Mutlu N, Turkeri L, Emerk K. Analytical and clinical evaluation of a new urinary tumor marker: bladder tumor fibronectin in diagnosis and follow-up of bladder cancer. Clin Chem Lab Med 2003; 41: 10691074.

    • Search Google Scholar
    • Export Citation
  • 35.

    Menendez V, Fernandez-Suarez A, Galan JA, et al. Diagnosis of bladder cancer by analysis of urinary fibronectin. Urology 2005; 65: 284289.

  • 36.

    Eissa S, Swellam M, Sadek M, et al. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors. J Urol 2002; 168: 465469.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 37.

    Malmstrom PU, Larsson A, Johansson S. Urinary fibronectin in diagnosis and follow-up of patients with urinary bladder cancer. Br J Urol 1993; 72: 307310.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 38.

    Bray BA, Osman M, Ashtyani H, et al. The fibronectin content of canine lungs is increased in bleomycin-induced fibrosis. Exp Mol Pathol 1986; 44: 353363.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 39.

    Eismann U, Sommer M, Kosmehl H, et al. Fibronectin splice variants—prognostic markers for the stage of renal interstitial fibrosis in the rat. Nephron 2002; 92: 379388.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 40.

    Stanislawski L, Sorin M. Modifications of plasma fibronectin in cystic fibrosis patients. Infect Immun 1991; 59: 949954.

  • 41.

    Zhang K, Rekhter MD, Gordon D, et al. Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study. Am J Pathol 1994; 145: 114125.

    • Search Google Scholar
    • Export Citation
  • 42.

    Kolachala VL, Bajaj R, Wang L, et al. Epithelial-derived fibronectin expression, signaling, and function in intestinal inflammation. J Biol Chem 2007; 282: 3296532973.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 43.

    Cheng CY, Martin DE, Leggett CG, et al. Fibronectin enhances healing of excised wounds in rats. Arch Dermatol 1988; 124: 221225.

Advertisement